Navigation Links
High doses of antioxidant supplements induce stem cell genetic abnormalities
Date:5/4/2010

LOS ANGELES (May 5, 2010) High doses of antioxidant nutritional supplements, such as vitamins C and E, can increase genetic abnormalities in cells, which may predispose supplement-takers to developing cancer, according to a new study from the Cedars-Sinai Heart Institute.

The study, led by Eduardo Marbn, M.D., Ph.D., director of the Cedars-Sinai Heart Institute, was published online today in the medical journal Stem Cells. The study also will appear in the journal's July printed edition.

Marbn and his team accidentally discovered the danger of excessive antioxidant doses while seeking a way to reduce the genetic abnormalities that occurred naturally when the scientists sought to multiply human cardiac stem cells.

Marbn stressed that the study's finding applies only to excessive nutritional supplements and not to foods that are rich in antioxidants, such as milk, oranges, blueberries and peanuts. In recent years, multiple studies have touted the benefits of foods rich in antioxidants.

"Taking one multivitamin daily is fine, but a lot of people take way too much because they think if a little is good, a lot must be better," said Marbn, who is also the Mark Siegel Family Professor at Cedars-Sinai. "That is just not the case. If you are taking 10 or 100 times the amount in a daily multivitamin, you may be predisposing your cells to developing cancer, therefore doing yourself more harm than good."

In laboratories, stem cells are often grown in a Petri dish culture than is composed of 20 percent oxygen, whereas cells growing inside human tissue are exposed to just 3 to 5 percent oxygen. But Marbn's team of researchers became frustrated because the higher concentration of oxygen in lab-grown stem cells resulted in 9 percent of the cells being rejected because of genetic abnormalities.

"We sought to counter that oxidation problem by adding high doses of antioxidants directly to the cells," Marbn said. "That's when we made the serendipitous discovery that there is a danger zone for the cells exposed to antioxidants to develop genetic abnormalities that predispose to cancer."

Marbn is leading an ongoing, groundbreaking clinical trial in which heart attack patients undergo two minimally-invasive procedures in an effort to repair and re-grow healthy muscle in a heart injured by a heart attack. First, a biopsy of each patient's own heart tissue is used to grow specialized heart stem cells. About a month later, the multiplied stem cells are then injected back into the patient's heart via a coronary artery.

The two-step procedure was completed on the first patient in June 2009. The results of the trial are expected in early 2011.

Recently, Marbn received a $5.5 million grant from the California Institute for Regenerative Medicine to continue developing cardiac stem cell therapies.


'/>"/>

Contact: Sally Stewart
Sally.stewart@cshs.org
310-248-6566
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. Botox reduces wrinkles even in less frequent doses
2. Children with food allergies should carry 2 doses of emergency medicine
3. ASTRO publishes supplement on protecting cancer patients by reducing radiation doses, side effects
4. More Doses of MS Drug Raise Risk of Brain Infection
5. Child-specific doses for pediatric PET patients
6. Overdoses From Prescription Painkillers on the Rise
7. More Than 4 Million Doses of H1N1 Vaccine Allocated to Pennsylvania Since Start of Vaccination Effort
8. Nearly 5 Million Doses of Nasal Swine Flu Vaccine Recalled
9. Variable Doses of Radiation Raise Safety Concerns for CT Procedures
10. Nearly 3 Million Doses of H1N1 Vaccine Allocated to Pennsylvania since Start of Vaccination Effort
11. Cloves are the best natural antioxidant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2020)... ... June 28, 2020 , ... ... world, dedicates World Allergy Week, from June 28 to July 4, 2020, to ... CoV-2. , COVID-19, short for “coronavirus disease 2019”, is a disease spreading around ...
(Date:6/25/2020)... , ... June 25, 2020 , ... Denials Management, Inc. ... on the key steps when filing appeals for denials of mental health and substance ... help educate individuals about their appeal rights and explain the steps in the appeals ...
(Date:6/24/2020)... ... June 24, 2020 , ... At Allerio we have chosen to do ... remote communications. We knew it had to be portable, it had to be reliable, ... has to work. , We are proud to announce that Allerio has passed all ...
(Date:6/24/2020)... ... June 24, 2020 , ... ... today announced that Wexford Physician Hospital Organization (PHO) has successfully deployed SPH’s Population ... within the framework of value-based care. Use of Population Care is benefitting more ...
(Date:6/24/2020)... ... June 24, 2020 , ... Skyroam , the developer of patented virtual ... , the leading provider of enterprise software for testing laboratories, in which its Skyroam ... new Portable Disease Surveillance Lab (PDSL) kit. , “Stopping the spread of COVID-19 is ...
Breaking Medicine News(10 mins):
(Date:6/25/2020)... ... June 25, 2020 , ... R3 Medical Training announced ... place in August at several locations. The first course is August 6-7, 2020 in ... course is being offered as a Virtual Live Stream option. , The two day ...
(Date:6/25/2020)... ... 25, 2020 , ... BeCurious Studio LLC was named as ... the launch a recent project. BeCurious Studio, the rule breaking web/app development hub, ... Commissioned by MyVictory Inc , the platform delivers a seamless, individualized healthcare ...
(Date:6/25/2020)... ... , ... The Heritage Downtown Active Senior Living Apartment Homes in Walnut Creek, ... positive cases of the coronavirus in the United States to date, their announcement is ... their family members, as well as the Walnut Creek community. , “Our staff ...
Breaking Medicine Technology: